Ponvory
by Johnson & Johnson
Ponvory is a once-daily oral treatment for relapsing multiple sclerosis available through the Johnson & Johnson Patient Assistance Program.
Ponvory (ponesimod) is a selective sphingosine 1-phosphate (S1P) receptor 1 modulator approved for adults with relapsing forms of multiple sclerosis (MS) — including clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS — to reduce the frequency of relapses and delay disability progression. It works by retaining lymphocytes in lymph nodes, reducing the number of circulating immune cells that can attack the myelin sheath. Ponvory is started with a 14-day titration regimen to allow the heart rate effects to stabilize, after which it is taken as a once-daily 20 mg tablet.
Patient assistance programs
Johnson & Johnson Patient Assistance Program (J&J withMe)
Manufacturer PAP- Eligibility
- Uninsured or underinsured adults with a valid Ponvory prescription from a licensed U.S. healthcare provider who meet income requirements.
- Income limit
- Varies based on household size; generally ≤400% of Federal Poverty Level (FPL)
- Insurance
- Uninsured or underinsured
- How to apply
- Apply through ClariMeds — we handle all paperwork at no cost to you. Applications are submitted directly to J&J withMe on your behalf.
- Phone
- 1-800-652-6227
Need help applying?
ClariMeds handles the entire application process for you — for free. See if you qualify in minutes.
See If You Qualify — Free